AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $259,000 | -42.7% | 22,000 | -28.1% | 0.00% | 0.0% |
| Q2 2020 | $452,000 | +9.4% | 30,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $413,000 | -44.2% | 30,600 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $740,000 | +29.4% | 30,600 | +2.9% | 0.00% | 0.0% |
| Q3 2019 | $572,000 | -36.2% | 29,740 | -2.0% | 0.00% | -33.3% |
| Q2 2019 | $897,000 | -28.9% | 30,340 | +14.3% | 0.00% | -40.0% |
| Q1 2019 | $1,261,000 | +344.0% | 26,555 | +532.3% | 0.01% | +400.0% |
| Q2 2018 | $284,000 | +24.6% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $228,000 | +6.0% | 4,200 | +16.7% | 0.00% | 0.0% |
| Q4 2017 | $215,000 | +5.4% | 3,600 | -14.3% | 0.00% | 0.0% |
| Q3 2017 | $204,000 | +7.9% | 4,200 | +16.7% | 0.00% | 0.0% |
| Q2 2017 | $189,000 | +16.0% | 3,600 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $163,000 | +19.9% | 3,601 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $136,000 | +16.2% | 3,601 | +16.2% | 0.00% | 0.0% |
| Q3 2016 | $117,000 | +85.7% | 3,100 | -13.9% | 0.00% | – |
| Q2 2016 | $63,000 | +270.6% | 3,600 | +157.1% | 0.00% | – |
| Q1 2016 | $17,000 | -29.2% | 1,400 | +40.0% | 0.00% | – |
| Q4 2015 | $24,000 | +4.3% | 1,000 | -23.1% | 0.00% | – |
| Q3 2015 | $23,000 | -63.5% | 1,300 | -35.0% | 0.00% | -100.0% |
| Q1 2015 | $63,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |